• Home
  • >>>>>>>>>>>>> 2026 & BEYOND MASTER PLAN >>>>>>>>>>>>>>>>
  • TRAINABLE DATA ASSETS IN CORPORATE LEGACY & ORGANIZATION’s STRATEGIC MEMORY (2012 – 2025)
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • Founder’s Vision
  • Portfolio of IP Assets
  • Knowledge PORTALS System (KPS)
  • 1.0 LPBI – 2012-2020 VISTA
  • LPBI Group’s History
  • 2.0 LPBI – 2021-2025 VISION
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder’s Bio
  • Funding, Deals & Partnerships
  • 1.0 LPBI Group News
  • 1.0 LPBI CALENDAR
  • 2.0 LPBI Group News
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2021 Summer Internship Portal
  • 2021-2025 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • Blockchain Transactions Network Ecosystem
  • 1.0 LPBI Brochure
  • 2.0 LPBI Brochure
  • 2.0 LPBI – Calendar of Zooms
  • Coronavirus, SARS-CoV-2 Portal
  • LPBI India
  • SOP Web STAT
  • Synthetic Biology in Drug Discovery
  • Certificate One Year
  • NFT: Redefined Format of IP Assets
  • Audio English-Spanish: BioMed e-Series
  • Five Bilingual BioMed e-Series
  • Press Releases
  • Intangibles CIM
  • BioMed Audio Podcast Library @LPBI Group
  • Medical School Education: Use of LPBI Group’s Contents
  • ChatGPT + Wolfram PlugIn
  • Medicine with GPT-4 & ChatGPT
  • AGI, generativeAI, Grok, DeepSeek & Expert Models in Healthcare
  • Multimodal Healthcare Foundation Model
  • Cell Therapy in Regenerative Medicine, 2026 and Beyond
  • Contact Us

Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA

Healthcare analytics, AI solutions for biological big data, providing an AI platform for the biotech, life sciences, medical and pharmaceutical industries, as well as for related technological approaches, i.e., curation and text analysis with machine learning and other activities related to AI applications to these industries.

Feeds:
Posts
Comments

John Lahaye, INACTIVE, 8/22/2024 – Member Business Advisory Board, Business Development CRO economic segment – PERSONAL PAGE

John Lahaye, Member Business Advisory Board, Business Development CRO economic segment

https://pharmaceuticalintelligence.com/contributors-biographies/business-development-private-equity-investment/john-lahaye-member-business-advisory-board-business-development-cro-economic-segment/

 

The Record

Updated on 5/3/2024

LPBI Group IP Digital Assets Divestiture

Activity   IA CE NA IN CS PL SH
                 
Dates of Contact   February 12 2024
February 14 2024
March 4 2024
March 6 2024
March 8 2024
March 19 2024
March 27 2024
March 28 2024		 March 31 2024
April 1 2024
April 4 2024		 March 21 2024
March 28 2024
March 31 2024
April 2 2024		 April 23 2024 April 23 2024 April 23 2024 April 23 2024
                 
Original Document Shared on   March 28 2024 March 31 2024 April 2 2024        
                 
Original Document Name   LPBI Group IP Asset Classes _ March 28 2024 _ IA _ v(Final).pptx LPBI Group IP Asset Classes _ March 31 2024 _ CE _ v(Final).pptx LPBI Group IP Asset Classes _ April 2 2024 _ NA _ v(Final _ c).pptx        
                 
Modified Document Shared on   Not Applicable April 4 2024 Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable
                 
Modified Document Name   Not Applicable LPBI Group IP Asset Classes _ April 4 2024 _ CE _ v(Final _ c).pptx Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable
                 
Follow ups / Feedback   Expecting Feedback week of April 15 2024 Expecting Feedback week of May 6, 2024 April 9 2024
No interest from NA.
“The data is all medical and pharmaceutical focused and would only be useful for a medical fine-tuned model.  We already have enough medical content in our foundational model.” 		        
                 
Participants   SH
VP & GM Commercial Technology
RK
President of Real World Solutions
PR
Corporate Development
MZ
VP Global Head DataStrategy, Access & Enablement		 RC
SVP and Managing Director, Life Sciences & Healthcare Strategy		 IL
Head of Capital 		 BH
Senior Vice President & General Manager		 MW
Senior Manager, Global Oncology Business Development, Discovery Services		 DB
SVP, Digital Enablement & Innovation		 DH
SVP, Business Strategy,Insights & Market Development
PM
President & Global Head Deployment Solutions

 

 

 

Share this:

  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Facebook (Opens in new window) Facebook
  • Print (Opens in new window) Print
  • Email a link to a friend (Opens in new window) Email

Like this:

Like Loading...

  • Follow Blog via Email

    Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 2,056 other subscribers

  • Recent Posts

    • Grok thinks like PhDs – Hybrid Model for Autonomous Update of Doctoral Dissertations with Original PhD Student Author editing and acceptance of Grok’s updated output. 3rd Joint article, a pilot study for Validation of an Autonomous Journal Articles Updating System (AJAUS) tested on Autonomous Update of Aviva Lev-Ari, PhD, RN Doctoral Thesis, UC, Berkeley, 1983. January 31, 2026
    • 2026 World Economic Forum, 1/19 – 1/23/2026, Davos, Switzerland, LPBI Group’s KOLs interpretation of AI in Health Videos January 24, 2026
    • Evolving LPBI Group’s Portfolio of Intellectual Properties (IP): From 2021 Vision to 2026 Reality January 12, 2026
    • Aviva Lev-Ari, PhD, RN – Biography ->> Grokepedia Entry January 11, 2026
    • List of Articles included in the Article SELECTION from Collection of Aviva Lev-Ari, PhD, RN Scientific Articles on PULSE on LinkedIn.com for Training Small Language Models (SLMs) in Domain-aware Content of Medical, Pharmaceutical, Life Sciences and Healthcare by 15 Subjects Matter January 10, 2026
    • Article SELECTION from Collection of Aviva Lev-Ari, PhD, RN Scientific Articles on PULSE on LinkedIn.com for Training Small Language Models (SLMs) in Domain-aware Content of Medical, Pharmaceutical, Life Sciences and Healthcare by 15 Subjects Matter January 10, 2026
    • Collection of Aviva Lev-Ari, PhD, RN Scientific Articles on PULSE on LinkedIn.com January 10, 2026
    • The youngest leader in AI in Health: Tanishq Mathew Abraham, Ph.D. (@iScienceLuvr) January 8, 2026
    • 2026 Grok Multimodal Causal Reasoning on Proprietary Cariovascular Corpus: From 2021 Wolfram NLP Baseline to Thousands of Novel Relationships – A Second Head-to-Head Validation of LPBI’s Domain-Aware Training Advantage January 6, 2026
    • Workflow for Dynamic Linkage and Transition between two Authoring Systems: LPBI Group’s WordPress.com Multi-Authors Authoring System and Microsoft PowerPoint product for Slide show presentation – Part 10.1 in Composition of Methods January 6, 2026

  • Archives

  • Categories

  • Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    • 1 2012pharmaceutical
    • 1 sjwilliamspa

Powered by WordPress.com.

WPThemes.


%d